Skip to main content
Log in

Development and clinical application of an AFC regimen (Adriamycin, Futraful, Cytosine arabinoside) for superficial bladder tumors

  • Adriamycin, Futraful, Ara-C, Bladder Cancer
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Summary

Our AFC regimen was originally developed to treat superficial bladder tumors. It consists of a daily intravesical administration of 20 mg Adriamycin (ADM) and 200 mg Cytosine arabinoside (CA) dissolved in 20 ml of sterilized distilled water, simultaneously with a daily rectal suppository of 750 mg tegafur (Futraful) for a total of 20 applications.

Our study demonstrated the following characteristics of the AFC modality: (1) It is simple; (2) it is completed in 3 weeks, which is shorter than conventional bladder instillation therapy; (3) the effective rate is reasonable (70%); (4) no local side-effects were observed because the concentrations of ADM and CA were low; (5) interruption of therapy was unnecessary, because whatever general side-effects were caused, they disappeared within several days of completion of treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Araki H, Mishina T, Miyakoda K, Fujiwara T, Kobayashi T (1982) Cytosine arabinoside bladder instillation therapy for bladder tumors. Tohoku J Exp Med 136: 23

    Google Scholar 

  2. Harmer MH (1978) In: TNM classification of malignant tumors, 3rd edn. WHO, Geneva, p 113

    Google Scholar 

  3. Mishina T, Fujiwara T, Miyakoda K, Araki H, Kobayashi T, Saitoh M, Watanabe H (1979) Adriamycin instillation therapy for bladder tumors. Tohoku J Exp Med 127: 339

    Google Scholar 

  4. Mishina T, Watanabe H, Kobayashi T, Maegawa M, Nakao M, Nakagawa S (1983) Clinical application of Tegafur suppository for bladder tumors, (in press)

  5. Miyakoda K, Mishina T, Araki H, Fujiwara T, Kobayashi T, Watanabe H (1978) Basic study on the application of FT-207 suppository for urogenital malignant tumors. Acta Urologica Japonica 24: 55

    Google Scholar 

  6. Ozaki Y (1977) Bladder instillation of Adriamycin in the treatment of bladder tumors. 1. Clinical results. Jpn J Urol 68: 934

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mishina, T., Kobayashi, T., Maegawa, M. et al. Development and clinical application of an AFC regimen (Adriamycin, Futraful, Cytosine arabinoside) for superficial bladder tumors. Cancer Chemother. Pharmacol. 11 (Suppl 1), S89–S90 (1983). https://doi.org/10.1007/BF00256727

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00256727

Keywords

Navigation